CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-008235
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Cyclin-dependent kinase inhibitor 1C 
Protein Synonyms/Alias
 Cyclin-dependent kinase inhibitor p57; p57Kip2 
Gene Name
 CDKN1C 
Gene Synonyms/Alias
 KIP2 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
286RKRSAPEKSSGDVPAubiquitination[1]
Reference
 [1] Global identification of modular cullin-RING ligase substrates.
 Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y, Guo A, Chen YN, Rush J, Hsu PW, Yen HC, Elledge SJ.
 Cell. 2011 Oct 14;147(2):459-74. [PMID: 21963094
Functional Description
 Potent tight-binding inhibitor of several G1 cyclin/CDK complexes (cyclin E-CDK2, cyclin D2-CDK4, and cyclin A-CDK2) and, to lesser extent, of the mitotic cyclin B-CDC2. Negative regulator of cell proliferation. May play a role in maintenance of the non- proliferative state throughout life. 
Sequence Annotation
 REPEAT 156 159 1.
 REPEAT 160 163 2.
 REPEAT 180 183 3.
 REPEAT 184 187 4.
 REPEAT 188 191 5.
 REPEAT 198 201 6.
 REPEAT 202 205 7.
 REPEAT 206 209 8.
 REPEAT 210 213 9.
 REGION 156 213 9 X 4 AA repeats of P-A-P-A.
 MOTIF 278 281 Nuclear localization signal (Potential).
 MOD_RES 268 268 Phosphoserine.  
Keyword
 Alternative splicing; Cell cycle; Complete proteome; Disease mutation; Nucleus; Phosphoprotein; Protein kinase inhibitor; Reference proteome; Repeat; Tumor suppressor. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 316 AA 
Protein Sequence
MSDASLRSTS TMERLVARGT FPVLVRTSAC RSLFGPVDHE ELSRELQARL AELNAEDQNR 60
WDYDFQQDMP LRGPGRLQWT EVDSDSVPAF YRETVQVGRC RLLLAPRPVA VAVAVSPPLE 120
PAAESLDGLE EAPEQLPSVP VPAPASTPPP VPVLAPAPAP APAPVAAPVA APVAVAVLAP 180
APAPAPAPAP APAPVAAPAP APAPAPAPAP APAPAPDAAP QESAEQGANQ GQRGQEPLAD 240
QLHSGISGRP AAGTAAASAN GAAIKKLSGP LISDFFAKRK RSAPEKSSGD VPAPCPSPSA 300
APGVGSVEQT PRKRLR 316 
Gene Ontology
 GO:0005737; C:cytoplasm; IDA:BHF-UCL.
 GO:0005634; C:nucleus; IDA:BHF-UCL.
 GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; TAS:ProtInc.
 GO:0007050; P:cell cycle arrest; TAS:ProtInc.
 GO:0000080; P:G1 phase of mitotic cell cycle; TAS:ProtInc.
 GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:BHF-UCL.
 GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Compara.
 GO:0045892; P:negative regulation of transcription, DNA-dependent; IDA:UniProtKB.
 GO:0042551; P:neuron maturation; IEA:Compara.
 GO:0001890; P:placenta development; IEA:Compara.
 GO:0045893; P:positive regulation of transcription, DNA-dependent; IGI:UniProtKB.
 GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:BHF-UCL.
 GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc. 
Interpro
 IPR003175; CDI. 
Pfam
 PF02234; CDI 
SMART
  
PROSITE
  
PRINTS